Inhalable Multifunctional Liposomes Disrupt the Inflammation-Oxidative Stress Cycle for Acute Lung Injury Therapy
ACS Nano · 10.11.2026 · 20 (44) · 29682-29699
DOI: 10.1021/acsnano.6c10873 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 23.10.2026. Verfasst von Rui-Qi Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongnan Hospital, Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan Universi…. Hauptthemen laut MEDLINE: Liposomes, Acute Lung Injury, Oxidative Stress, Inflammation. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Hubei Province Science and Technology Innovation Talent Program.
Abstract (Originalsprache)
Acute lung injury (ALI) is characterized by an uncontrolled cycle of inflammation and oxidative stress. However, conventional therapeutics are limited by physiological pulmonary barriers and poor targeted bioavailability. In this study, an inhalable multifunctional liposomal system (designated as R&I/Lip@PEG-M) was elaborately engineered to codeliver Resveratrol and IMD-0354 to disrupt the inflammation-oxidative stress cycle for ALI therapy. Upon nebulized inhalation, the negatively charged R&I/Lip@PEG-M liposomes would efficiently penetrate the mucus barrier, extensively accumulate in the pulmonary alveoli, and be specifically taken up by alveolar macrophages via mannose-mediated targeting recognition. Particularly, the internalized liposomes could exert combined therapeutic effects by scavenging intracellular reactive oxygen species (ROS) and blocking the NF-κB signaling pathway to inhibit inflammation. In the LPS-induced ALI mouse model, the designed R&I/Lip@PEG-M significantly reduced the population of inflammatory macrophages, reprogrammed the redox microenvironment, and successfully mitigated lung damage and pulmonary edema.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Zhongnan Hospital, Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan430072, P. R. China.
- School of Chemistry and Chemical Engineering, Chongqing University, Chongqing400044, P. R. China.
ORCID-Profile: Wei-Hai Chen, Xian-Zheng Zhang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Hubei Province Science and Technology Innovation Talent Program
Zitieren
APA
Zhao, R. Q., Zhang, S. M., Xie, J. M., Ran, Z. H., Wang, Y. Z., Liu, J. H., Chen, H., Chen, W. H., & Zhang, X. Z. (2026). Inhalable Multifunctional Liposomes Disrupt the Inflammation-Oxidative Stress Cycle for Acute Lung Injury Therapy. ACS Nano, 20(44), 29682-29699. https://doi.org/10.1021/acsnano.6c10873
Vancouver
Zhao RQ, Zhang SM, Xie JM, Ran ZH, Wang YZ, Liu JH, et al. Inhalable Multifunctional Liposomes Disrupt the Inflammation-Oxidative Stress Cycle for Acute Lung Injury Therapy. ACS Nano. 2026;20(44):29682-29699. doi:10.1021/acsnano.6c10873
BibTeX
@article{Zhao2026,
author = {Zhao, Rui-Qi and Zhang, Shi-Man and Xie, Jia-Min and Ran, Ze-Han and Wang, Yu-Zhang and Liu, Jia-Hao and Chen, Hong and Chen, Wei-Hai and Zhang, Xian-Zheng},
title = {Inhalable Multifunctional Liposomes Disrupt the Inflammation-Oxidative Stress Cycle for Acute Lung Injury Therapy},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {44},
pages = {29682--29699},
doi = {10.1021/acsnano.6c10873}
}
EUVIMED